Several months after telegraphing a major antibody-drug conjugate manufacturing expansion in its native Switzerland, CDMO ...

For that indication, Rytelo is dosed at 7.1 mg/kg administered as an intravenous infusion every four weeks. Thrombocytopenia ...

Stopping short of a formal declaration allowing their use, Department of Health and Human Services secretary Robert F. Kennedy Jr. | Stopping short of a formal declaration allowing their use, ...

Biogen’s third quarter revenues beat out Wall Street estimates in what CEO Chris Viehbacher called “one of these quarters where the numbers almost just speak for themselves.” | Biogen CEO Chris ...

Amgen has been handed an FDA warning letter over a video promoting its cancer drug Vectibix, but the company said the issues ...

GSK's chief executive Luke Miels has committed to a transparent communication strategy after telling analysts during its Q3 ...

Strategic consulting firm Blue Matter is boosting its communications digs with the acquisition of global healthcare ...

Eli Lilly is consolidating its U.S. and international commercial divisions into a unified department, tapping current U.S.

As a cornerstone of Merck & Co.’s post-Keytruda oncology strategy, sac-TMT has cleared a clinical milestone. | As a ...

Vanda Pharmaceutical’s Nereus may soon break out of its motion sickness niche to become a treatment option for the burgeoning ...

Pfizer’s Elrexfio has taken another step on its path to potential commercial momentum: The drugmaker just announced another ...

Things have been relatively quiet on the layoff front for the company in 2026, although it was widely reported in June that ...